The esophagogastric junctional adenocarcinoma an increasing disease [PDF]
, 2017 Identifying and defining the esophagogastric junctional adenocarcinoma (EGJA) as an independent disease apart from gastric cancer (GC) and esophagus cancer (EG) it has always been a difficult issue entailing doubts about the appropriate therapeutic ...
Andreetti, Claudio +3 more
core +1 more source
Comprehensive molecular characterization of gastric adenocarcinoma
Nature, 2014 Gastric cancer is a leading cause of cancer deaths, but analysis of its molecular and clinical characteristics has been complicated by histological and aetiological heterogeneity.
A. Bass +259 more
semanticscholar +1 more source
Modified Porro’s Operation in Ovarian Cancer: a Clinical Case
Креативная хирургия и онкология, 2021 Background. Ovarian cancer in pregnancy is quite rare having a top 5th incidence among other pregnancy-associated tumours [1]. Due to a low population rate in pregnant women, the lack of standardised management of such patients and the paucity of ...
A. G. Yashchuk +4 more
doaj +1 more source
Anti epidermal growth factor receptor therapy in small bowel adenocarcinoma [PDF]
, 2018 Rationale:Small bowel adenocarcinoma (SBA) is an uncommon gastrointestinal cancer, thus limited data about treatment for advanced disease are available.
Anselmi, Elisabetta +4 more
core +1 more source
Indian Journal of Neurosurgery, 2017 Brain tumors in pregnancy are rare phenomenon with variable outcomes. We present a case of adenocarcinoma cerebrum originated from the lung in a 24-year-old primigravida woman.
Rahul Awasthi +4 more
doaj +1 more source
Expression of LDL receptor-related proteins (LRPs) in common solid malignancies correlates with patient survival [PDF]
, 2017 LDL receptor-related proteins (LRPs) are transmembrane receptors involved in endocytosis, cell-signaling, and trafficking of other cellular proteins. Considerable work has focused on LRPs in the fields of vascular biology and neurobiology.
Gilder, Andrew S. +4 more
core +7 more sources
Integrative Proteomic Characterization of Human Lung Adenocarcinoma.
Cell, 2020 Genomic studies of lung adenocarcinoma (LUAD) have advanced our understanding of the disease's biology and accelerated targeted therapy. However, the proteomic characteristics of LUAD remain poorly understood.
Junming Xu +43 more
semanticscholar +1 more source
Lung Adenocarcinoma Tumor Origin: A Guide for Personalized Medicine
Cancers, 2022 Simple Summary Lung cancer is the leading cause of cancer-related death worldwide, with an average 5-year survival rate of approximately 15%. Among the multiple histological type of lung cancer, adenocarcinoma is the most common.
L. Seguin, M. Durandy, C. Féral
semanticscholar +1 more source
MAP17 predicts sensitivity to platinum-based therapy, EGFR inhibitors and the proteasome inhibitor bortezomib in lung adenocarcinoma [PDF]
, 2018 Background The high incidence and mortality of lung tumours is a major health problem. Therefore, the identification both of biomarkers predicting efficacy for therapies in use and of novel efficacious therapeutic agents is crucial to increase patient ...
Carnero Moya, Amancio +5 more
core +1 more source
Treatment utilization and outcomes in elderly patients with locally advanced esophageal carcinoma: A review of the National Cancer Database [PDF]
, 2017 For elderly patients with locally advanced esophageal cancer, therapeutic approaches and outcomes in a modern cohort are not well characterized. Patients ≥70 years old with clinical stage II and III esophageal cancer diagnosed between 1998 and 2012 were ...
Bradley, Jeffrey D +10 more
core +2 more sources